Novavax vaccine works well except on N501Y.V2 South Africa variant

Africa, Coronavirus, England, Europe, Health, Infection, Mutation, N501Y, Northern Ireland, Science, Scotland, South Africa, UK, Vaccine, Wales

An early analysis in Britain found that the Novavax vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just under 50 percent.


Image by Arek Socha from Pixabay

** This post was originally published on January 28, 2021 **